| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9769259 | European Journal of Medicinal Chemistry | 2005 | 4 Pages |
Abstract
Because Alzheimer's disease (AD) is a medical problem characterized by progressive loss of memory and cognition that is associated with a deficient cholinergic system, this work aims to evaluate some p-aminobenzoic acid (PABA) derivatives as acetylcholinesterase inhibitors in vitro, in continuation with our last studies. The assayed compounds are low toxic, simple-structured and low cost.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
José Correa-Basurto, Iván Vázquez Alcántara, L. Michel Espinoza-Fonseca, José G. Trujillo-Ferrara,